RecruitingNCT06541860
DAratumumab and REvlimid REfractory MM
Salvage Regimens in Multiple Myeloma Patients Double Refractory to Lenalidomide and MoAbs: Evidence From Real World Experience
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Enrollment
100 participants
Start Date
Aug 21, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Retrospective and prospective multicenter observational study on patients with relapsed and refractory multiple myeloma after anti-CD38 MoAb therapy and IMIDS treated with onlabel regimens.
Eligibility
Min Age: 18 Years
Inclusion Criteria8
- Phase I
- Patients with RRMM after therapy with anti-CD38 MoAb plus IMIDS started on therapy with PVD scheme
- Patients aged ≥ 18 years
- Patients able to understand and voluntarily sign an informed consent and be willing to consent to the review of clinical data
- Phase II
- Patients with RRMM after first-line therapy with anti-CD38 MoAb plus IMIDS started on therapy with on-label schemes
- Patients aged ≥ 18 years
- Patients able to understand and voluntarily sign an informed consent and be willing to consent to the review of clinical data
Exclusion Criteria1
- Patients not willing to consent to review of clinical data
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06541860
Related Trials
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
NCT0725851133 locations
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
NCT0617988873 locations
Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma
NCT068761421 location
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
NCT0698048016 locations
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
NCT0582851132 locations